BBLG
Bone Biologics Corporation
NASDAQHealthcareMedical - DevicesUS
Rating:C+
Company Profile
CEO
Jeffrey Frelick
IPO Date
2021-10-13
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Bone Biologics Corporation
CEO
Jeffrey Frelick
IPO Date
2021-10-13
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 16,668 |
| $1.55 |
| 6 Jun 2025 | Meikle Phillip Terry II | director | A-Award | Acquired | 62,894 | $0.88 |
| 6 Jun 2025 | Angle Siddhesh Rajendra | director | A-Award | Acquired | 62,894 | $0.88 |
| 6 Jun 2025 | Stroever Bruce | director | A-Award | Acquired | 62,894 | $0.88 |
| 6 Jun 2025 | Gagnon Robert E. | director | A-Award | Acquired | 62,894 | $0.88 |
| 21 Jan 2025 | Frelick Jeff | Chief Executive Officer | A-Award | Acquired | 54,110 | $0.97 |
| 21 Jan 2025 | Walsh Deina H | Chief Financial Officer | A-Award | Acquired | 27,055 | $0.97 |
| 19 Sept 2024 | Gagnon Robert E. | director | A-Award | Acquired | 30,713 | $1.73 |
| 19 Jan 2024 | Frelick Jeff | Chief Executive Officer | A-Award | Acquired | 25,000 | $3.61 |